Eribulin Mesylate
- Product NDC
- 0781-3391
- 11-digit product format
- 007813391
- Labeler code
- 0781
- Product ID
- 0781-3391_d122f0a4-aff7-49f7-8cf1-06bc2883ad43
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- eribulin mesylate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Sandoz Inc
- Application
- ANDA214310
- Marketing category
- ANDA
- Marketing start
- 2025-07-07
- Substance
- ERIBULIN MESYLATE
- Active strength
- .5 mg/mL
- Pharmacologic classes
- Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| AV9U0660CW | ERIBULIN MESYLATE | 441045-17-6 | ERIBULIN MESYLATE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0781-3391-94 | 00781339194 | 1 VIAL in 1 CARTON (0781-3391-94) / 2 mL in 1 VIAL | 1 vial | 2025-07-07 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Eribulin Mesylate | Sandoz Inc | 2024-10-02 | HUMAN PRESCRIPTION DRUG LABEL | 1 |